{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:30:44Z","timestamp":1793755844016,"version":"4.6.1"},"reference-count":11,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,6]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>This prespecified AZALEA-TIMI 71 analysis showed that prior oral anticoagulation (OAC) experience indicates bleeding risk in atrial fibrillation. The factor XI inhibitor abelacimab reduced bleeding regardless of prior OAC experience, with potentially greater absolute benefit among OAC-na\u00efve patients. This trial was registered at www.ClinicalTrials.gov as NCT04755283.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2026033829","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:20:20Z","timestamp":1780075220000},"page":"789-792","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9775-398X","authenticated-orcid":false,"given":"Andre M.","family":"Small","sequence":"first","affiliation":[{"name":"1Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth M.","family":"Patel","sequence":"additional","affiliation":[{"name":"2Thrombolysis in Myocardial Infarction Study Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"3Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[{"name":"2Thrombolysis in Myocardial Infarction Study Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"3Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Morrow","sequence":"additional","affiliation":[{"name":"2Thrombolysis in Myocardial Infarction Study Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"3Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-264X","authenticated-orcid":false,"given":"Erica L.","family":"Goodrich","sequence":"additional","affiliation":[{"name":"2Thrombolysis in Myocardial Infarction Study Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"3Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3819-2779","authenticated-orcid":false,"given":"Bruce","family":"Hug","sequence":"additional","affiliation":[{"name":"4Anthos Therapeutics, Inc, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanobar","family":"Parkar","sequence":"additional","affiliation":[{"name":"4Anthos Therapeutics, Inc, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9085-0823","authenticated-orcid":false,"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[{"name":"5Heart Rhythm Center, Cardiovascular Center, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"6Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang Ming Chiao Tung, University, Taipei, Taiwan"},{"name":"7Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan"},{"name":"8National Chung Hsing University, Taichung, Taiwan"},{"name":"9China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-2440","authenticated-orcid":false,"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[{"name":"10Division of Cardiology, Department of Medicine, St Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"11Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada"},{"name":"12Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-7225","authenticated-orcid":false,"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[{"name":"13Division of Cardiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert G.","family":"Kiss","sequence":"additional","affiliation":[{"name":"14Department of Cardiology, Central Hospital of Northern Pest-Military Hospital, Heart and Vascular Centre, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Wojakowski","sequence":"additional","affiliation":[{"name":"15Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[{"name":"16Thrombolysis and Atherosclerosis Research Institute, Hamilton Health Sciences, and McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"4Anthos Therapeutics, Inc, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0691-3359","authenticated-orcid":false,"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[{"name":"2Thrombolysis in Myocardial Infarction Study Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"3Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Ruff","sequence":"additional","affiliation":[{"name":"2Thrombolysis in Myocardial Infarction Study Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"3Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2026080611220374800_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"9921","key":"2026080611220374800_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"The Lancet"},{"issue":"1","key":"2026080611220374800_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE registry","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"11","key":"2026080611220374800_bib4","doi-asserted-by":"crossref","first-page":"e2242964","DOI":"10.1001\/jamanetworkopen.2022.42964","article-title":"Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010-2020","volume":"5","author":"Ko","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2026080611220374800_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"},{"issue":"9","key":"2026080611220374800_bib6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1182\/blood-2016-09-742262","article-title":"Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events","volume":"129","author":"Preis","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2026080611220374800_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCULATIONAHA.125.074037","article-title":"Abelacimab versus rivaroxaban in patients with atrial fibrillation on antiplatelet therapy: a prespecified analysis of the AZALEA-TIMI 71 trial","volume":"152","author":"Al Said","year":"2025","journal-title":"Circulation"},{"issue":"4","key":"2026080611220374800_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMoa2406674","article-title":"Abelacimab versus rivaroxaban in patients with atrial fibrillation","volume":"392","author":"Ruff","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"2026080611220374800_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carcinelli","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"2026080611220374800_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12872-019-1116-1","article-title":"Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment na\u00efve non-valvular atrial fibrillation patients in the US Department of Defense population","volume":"19","author":"Gupta","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"2026080611220374800_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamacardio.2025.0277","article-title":"Asundexian or apixaban in patients with atrial fibrillation according to prior oral anticoagulant use: a subgroup analysis of the OCEANIC-AF randomized clinical trial","volume":"10","author":"Alexander","year":"2025","journal-title":"JAMA Cardiol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/6\/789\/2536525\/blood_bld-2026-033829-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/6\/789\/2536525\/blood_bld-2026-033829-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:22:13Z","timestamp":1786029733000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/6\/789\/568803\/Prior-anticoagulation-experience-and-bleeding-risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026033829","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,6]]},"published":{"date-parts":[[2026,8,6]]}}}